Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Talis Biomedical Corp changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 740.9K | 796.6K | +55.7K (+7.5%) |
| Value | $4.27M | $5.93M | +$1.66M (+38.8%) |
New holders (2)
Institutions that held Talis Biomedical Corp at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 42,743 | $318.4K | 0.25% |
| Citadel Advisors LLC | 10,024 | $74.7K | 0.00% |
Sold out (3)
Institutions that held Talis Biomedical Corp at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Deutsche Bank AG | 600 | $3.46K |
| Royal Bank of Canada | 281 | $2.00K |
| New England Capital Financial Advisors LLC | 1 | $6 |